Actavis sues FDA regarding delay in approval of generic Celebrex
Actavis maintains that the FDA improperly awarded sole exclusivity on generic Celebrex to Teva Pharmaceutical Industries despite an earlier ruling from the US Court of Appeals for the
Actavis maintains that the FDA improperly awarded sole exclusivity on generic Celebrex to Teva Pharmaceutical Industries despite an earlier ruling from the US Court of Appeals for the
The acquisition is subject to receipt of customary regulatory approvals and approval by Furiex shareholders. Forest concurrently announced that it has entered into an agreement with Royalty Pharma
Anoro Ellipta is a combination anticholinergic/long-acting beta2-adrenergic agonist (anticholinergic/LABA) indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.
The agreement includes cell line optimization, analytical development and manufacturing scale-up activities for Omni Bio’s leading AAT Fc fusion protein with the goal of providing cGMP product to
Neumedicines’ proposal, ‘Recombinant Interleukin-12, a Broad-Spectrum Biologic for the Treatment of Battle and Traumatic Wound Infections’, was submitted in response to the Fiscal Year 2014 (FY14) Defense Medical
The grant, a Breast Cancer Research Program (BCRP) Breakthrough Award, was obtained by The University of Texas MD Anderson Cancer Center department of Surgical Oncology associate professor Dr
According to the agreement, Sinovac has committed to commercializing the vaccine in China, inclusive of conducting clinical trials, obtaining regulatory approval, and launching the sIPV vaccine. In addition,
Headed by project leader InnaVirVax, the consortium includes Diaxonhit, and two Inserm (French National Institute for Medical Research) units : Southern Paris University (CESP – U1018 – Kremlin
This rise in funding will support ongoing research into preventing cancer, developing new treatments and making existing ones more effective and personalised to the patient. The charity will
The announcement by Bill Gates, co-chair of the Bill & Melinda Gates Foundation, accompanied a commitment of significant funding by the Gates Foundation to determine the safety and